Real-world study of inclisiran vs PCSK9 monoclonal antibodies in patients with acute coronary syndrome

Authors
Category Primary study
JournalChin. J. New Drugs
Year 2025
This article has no abstract
Epistemonikos ID: a7dce9804b2d405798671682a2daa91fb3c9b7d5
First added on: Oct 14, 2025